R Squared’s MacroGenics MGNX Stock Holding History

R Squared’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43.7K	Sell	15,117 -774	-5%	-$1.65K	0.02%	425
2025 Q4	$25.6K	Buy	+15,891	New	+$25K	0.01%	485
2025 Q1	–	Sell	-570	Closed	-$1.85K	–	997
2024 Q4	$1.85K	Buy	+570	New	+$2.05K	﹤0.01%	1468

Other funds holding MGNX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

R Squared's MGNX Position: Q1 2026 in Review

R Squared reduced its MacroGenics (MGNX) stake by 4.9% in Q1 2026, selling an estimated $1.65K and leaving 15,117 shares worth $43.7K. The position accounts for 0.02% of the portfolio, ranked #425.

R Squared first reported a position in MGNX in Q4 2024 and has held it in 3 quarters since. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

R Squared held 15,117 shares of MacroGenics worth $43.7K as of Q1 2026.
R Squared sold 774 MacroGenics shares in Q1 2026, an estimated $1.65K.
MacroGenics made up 0.02% of R Squared's portfolio in Q1 2026, its #425 holding.
R Squared first reported a position in MacroGenics in Q4 2024 and has held it in 3 quarters since.
109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.